US EditionPublished • loading... • Updated
Exactly what business are we in with measles?
A CDC official described measles as an accepted consequence of public health policy, reflecting trade-offs in disease control strategies.
- Recently, a highly placed CDC official stated measles is a `cost of doing business,` in syndicated reporting.
- In a syndicated column, Harrop, a Creators Syndicate columnist, cited a CDC official calling measles a `cost of doing business` in a statement that gained national attention.
- Using the phrase `cost of doing business`, the syndicated piece quoted the senior CDC official presenting measles as an operational consequence for public-health practice.
- The comment prompted debate about whether some measles transmission is treated as an accepted trade-off in U.S. public-health practice, focusing on policy priorities and resource trade-offs.
- Given the national reach of Creators Syndicate, a senior CDC official's comment attracted widespread attention in public-health discourse, as it appeared in syndicated reporting.
Insights by Ground AI
17 Articles
17 Articles
Coverage Details
Total News Sources17
Leaning Left2Leaning Right0Center15Last UpdatedBias Distribution88% Center
Bias Distribution
- 88% of the sources are Center
88% Center
12%
C 88%
Factuality
To view factuality data please Upgrade to Premium
